Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tongling Jieya Biologic Technology
301108
5
XI'AN WONDER
836419
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | 96.27%449.31M | 32.41%711.04M | 110.03%539.92M | -16.90%245.59M | -19.07%228.93M | -6.01%536.99M | -30.87%257.08M | -4.81%295.56M | -16.37%282.87M | -0.74%571.31M |
Notes receivable and accounts receivable | -9.57%957.41M | -9.06%864.32M | 2.90%1.06B | 10.10%1.1B | 22.78%1.06B | 16.69%950.48M | 30.68%1.03B | 24.28%997.07M | 30.79%862.34M | 49.07%814.55M |
-Accounts receivable | -9.57%957.41M | -9.06%864.32M | 2.90%1.06B | 10.10%1.1B | 22.78%1.06B | 16.69%950.48M | 30.68%1.03B | 24.28%997.07M | 30.79%862.34M | 49.07%814.55M |
Other receivables (including interest and dividends) | 14.31%46.44M | 22.54%38.27M | 17.39%38.6M | 8.11%35.94M | 17.96%40.63M | 8.86%31.23M | 3.41%32.88M | 11.31%33.24M | -11.14%34.44M | -2.90%28.69M |
-Other receivable | ---- | ---- | ---- | 8.11%35.94M | ---- | 8.86%31.23M | ---- | 11.90%33.24M | ---- | -2.90%28.69M |
Contractual assets | -29.68%38.92M | -19.03%45.72M | -37.64%51.16M | -40.99%47.91M | -30.67%55.34M | -32.48%56.46M | -3.49%82.03M | 22.90%81.19M | 12.69%79.83M | 15.75%83.62M |
Advance payment | 14.15%1.06M | -16.72%3.84M | 200.50%4.84M | 163.49%4.34M | 33.38%932.02K | 547.39%4.61M | 43.40%1.61M | 82.22%1.65M | -70.17%698.78K | -49.44%712.36K |
Inventories | 55.30%850.88M | 72.56%696.27M | 41.21%778.03M | 16.90%616.07M | 7.28%547.9M | -2.71%403.5M | -18.68%550.95M | -19.02%527.01M | -17.13%510.71M | -18.79%414.73M |
Non-current assets due within one year | 136.07%15.46M | 121.95%17.46M | 161.54%9.69M | 54.14%5.87M | -6.95%6.55M | 26.27%7.87M | -8.11%3.7M | -5.03%3.81M | 134.95%7.04M | 206.75%6.23M |
Other current assets | 76.34%30.03M | 60.58%27.04M | 33.93%11.45M | 19.94%12.73M | 57.38%17.03M | 36.45%16.84M | -35.01%8.55M | -29.61%10.61M | -46.26%10.82M | 5.46%12.34M |
Total current assets | 22.16%2.39B | 19.72%2.4B | 26.78%2.49B | 5.95%2.07B | 9.35%1.96B | 3.92%2.01B | -0.29%1.97B | 3.76%1.95B | 2.28%1.79B | 10.43%1.93B |
Non Current assets | ||||||||||
Other equity investment | -18.69%26.03M | -18.69%26.03M | -21.64%32.02M | -21.67%32.02M | -20.33%32.02M | -20.33%32.02M | -12.33%40.86M | -12.29%40.88M | -12.00%40.19M | -12.00%40.19M |
Long-term equity investment | ---- | -91.93%73.82K | -2.70%565.93K | -18.98%525.58K | -56.66%728.08K | -55.20%915.3K | -80.43%581.65K | -81.60%648.69K | -55.66%1.68M | -51.24%2.04M |
Long term receivable account | 76.84%10.3M | 85.86%12.8M | -30.01%4.66M | -23.09%6.74M | -40.07%5.82M | -35.63%6.89M | -46.09%6.67M | -28.60%8.77M | -26.03%9.72M | -25.07%10.7M |
Fixed assets | ---- | ---- | ---- | -6.22%188.31M | ---- | -6.09%195.4M | ---- | -6.78%200.81M | ---- | -6.58%208.08M |
Intangible assets | -25.84%108.91M | -2.91%105.41M | -2.97%118.33M | -1.72%133.03M | -1.45%146.86M | -20.23%108.57M | -21.98%121.94M | -20.58%135.35M | 19.42%149.03M | 14.90%136.11M |
Development expenditure | 963.65%56.88M | 10.14%57.26M | 9.07%41.12M | -4.68%22.68M | -3.35%5.35M | 103.94%51.99M | 135.55%37.7M | 188.87%23.8M | -84.32%5.53M | -28.12%25.49M |
Goodwill | -27.52%40.93M | -27.10%41.14M | -26.29%56.14M | -25.60%56.88M | -22.96%56.47M | -24.25%56.44M | -33.45%76.16M | -31.18%76.46M | -32.20%73.29M | -31.36%74.51M |
Long deferred expense | 76.84%1.13M | 99.33%1.2M | -70.33%589.76K | -76.70%578.44K | -78.52%638.37K | -81.25%604.2K | -43.88%1.99M | -34.84%2.48M | -27.93%2.97M | -29.85%3.22M |
Deferred tax assets | 18.95%33.64M | 18.76%33.62M | -2.48%29.94M | -16.02%24.24M | 1.29%28.28M | 0.04%28.31M | -17.58%30.7M | -22.49%28.86M | -16.11%27.92M | -15.07%28.3M |
Usufruct assets | 26.32%6.03M | 3,398.85%6.55M | 629.42%4.08M | 369.94%4.44M | 195.16%4.78M | -91.39%187.22K | -81.90%560K | -76.06%944.24K | -66.17%1.62M | -51.64%2.17M |
Other non current assets | -8.75%15.33M | -18.57%13.64M | 10.55%22.27M | 8.11%19.38M | -8.50%16.8M | -12.69%16.76M | -12.55%20.14M | -51.69%17.93M | -15.54%18.36M | -16.95%19.19M |
Total non current assets | -2.20%478.8M | -3.45%480.89M | -7.49%494.61M | -8.96%488.83M | -8.46%489.59M | -9.44%498.08M | -14.78%534.63M | -17.36%536.93M | -12.84%534.81M | -10.55%550M |
Total assets | 17.28%2.87B | 15.12%2.88B | 19.45%2.99B | 2.73%2.56B | 5.25%2.45B | 0.96%2.51B | -3.79%2.5B | -1.67%2.49B | -1.65%2.32B | 4.98%2.48B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | -99.98%50K | ---- | -21.17%331.1M | 7.75%431M | 0.00%280M | -15.70%320M | -23.64%420M | -27.27%400M | -6.67%280M | 51.96%379.6M |
Notes payable and accounts payable | 130.44%31.56M | -7.13%34.74M | 356.55%47.65M | -25.45%13.97M | -9.52%13.69M | 166.87%37.41M | -29.21%10.44M | 31.43%18.74M | 6.41%15.14M | -43.21%14.02M |
-Accounts payable | 130.44%31.56M | -7.13%34.74M | 356.55%47.65M | -25.45%13.97M | -9.52%13.69M | 166.87%37.41M | -29.21%10.44M | 31.43%18.74M | 6.41%15.14M | -43.21%14.02M |
Contract liabilities | 80.91%468.89M | 96.70%444.66M | 31.44%341.23M | 2.52%263.15M | 13.49%259.18M | -2.77%226.06M | -8.62%259.6M | 1.58%256.68M | -20.09%228.38M | -19.15%232.49M |
Salaries payable | -15.17%141.22M | -17.01%138.07M | -0.28%112.12M | -5.14%105.72M | 16.04%166.47M | 16.02%166.36M | 10.04%112.44M | 3.51%111.44M | -13.52%143.46M | -12.44%143.39M |
Taxs payable | -14.98%48.29M | -5.72%65.52M | -0.63%56.56M | -10.68%52.89M | 21.24%56.8M | 18.17%69.49M | 27.03%56.92M | 38.59%59.22M | 22.06%46.85M | 5.29%58.8M |
Other payable (including interest and dividends) | -51.31%5.32M | 119.70%26.9M | 5.30%11.52M | -24.59%11.67M | -8.65%10.93M | -57.61%12.25M | -27.95%10.94M | 22.43%15.47M | -24.27%11.97M | 53.57%28.89M |
-Dividend payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --4.38M | ---- | ---- |
-Other payable | ---- | ---- | ---- | 5.23%11.67M | ---- | -57.61%12.25M | ---- | -12.26%11.09M | ---- | 53.57%28.89M |
Non current liabilities due within one year | 100.10%17.5M | 49.60%16.95M | 157.05%19.98M | -1.45%8.76M | -5.59%8.75M | 16.59%11.33M | -24.85%7.77M | -14.54%8.89M | -13.85%9.26M | -8.25%9.72M |
Total current liabilities | -10.43%712.83M | -13.77%726.85M | 4.79%920.17M | 1.92%887.16M | 8.27%795.82M | -2.77%842.9M | -14.03%878.12M | -12.11%870.44M | -11.53%735.05M | 6.89%866.92M |
Current liabilities | ||||||||||
Long term loan | ---- | ---- | ---- | -20.00%14.95M | -33.33%14.95M | -33.33%14.95M | -28.57%18.69M | -28.57%18.69M | -25.00%22.43M | -25.00%22.43M |
Long term salaries pay | -12.76%96.82K | 0.00%110.98K | -65.00%110.98K | -72.00%88.78K | -65.00%110.98K | -65.00%110.98K | -48.71%317.07K | -46.77%317.07K | -45.93%317.07K | -52.20%317.07K |
Estimate liabilities | 10.67%16.25M | -32.16%18.47M | -27.93%22.63M | -31.41%24.59M | 0.00%14.68M | -19.10%27.23M | 110.01%31.41M | 39.49%35.86M | 64.52%14.68M | 44.57%33.66M |
Deferred tax liabilities | 1,061.45%1.03M | 817.72%994.62K | 554.19%645.05K | 508.62%720.27K | -35.86%88.57K | -78.13%108.38K | -44.56%98.6K | -40.11%118.34K | -36.46%138.09K | 109.07%495.66K |
Lease liabilities | 1.45%3.73M | --4.58M | --2.6M | --3.14M | --3.67M | ---- | ---- | ---- | ---- | -90.52%117.28K |
Other non current liabilities | -57.85%15.88M | -57.04%16.82M | -42.20%33.58M | -35.16%37.69M | -39.02%37.66M | -36.67%39.16M | 0.53%58.1M | --58.12M | --61.76M | --61.85M |
Total non current liabilities | -48.04%36.98M | -49.76%40.98M | -45.15%59.57M | -28.22%81.18M | -28.35%71.17M | -31.38%81.57M | 4.32%108.62M | 111.13%113.1M | 141.59%99.32M | 114.86%118.86M |
Total liabilities | -13.52%749.81M | -16.94%767.83M | -0.71%979.75M | -1.55%968.35M | 3.91%866.98M | -6.22%924.46M | -12.33%986.74M | -5.79%983.55M | -4.31%834.38M | 13.78%985.78M |
Shareholders equity | ||||||||||
Paid-in capital | 10.98%812.25M | 10.92%812.07M | 10.17%805.06M | 0.15%731.87M | 0.05%731.87M | 0.09%732.14M | 1.36%730.77M | 1.36%730.77M | 1.45%731.47M | 1.45%731.47M |
Capital reserve funds | 85.54%942.63M | 84.58%940.01M | 79.25%870.01M | 6.38%516.33M | 7.73%508.03M | 8.01%509.26M | 18.94%485.37M | 18.32%485.37M | 14.45%471.58M | 14.43%471.49M |
Surplus reserve funds | 0.00%68.92M | 0.00%68.92M | 15.07%68.92M | 15.07%68.92M | 15.07%68.92M | 15.07%68.92M | 8.95%59.89M | 8.95%59.89M | 8.95%59.89M | 8.96%59.89M |
Retained profit | 4.00%324.56M | 3.57%327.15M | 6.17%312.54M | 9.76%310.4M | 7.11%312.09M | 6.31%315.88M | 3.06%294.37M | -1.25%282.79M | -1.22%291.37M | -2.52%297.14M |
Less:Treasury stock | -52.75%15.86M | -52.07%16.81M | -37.79%33.57M | -37.79%33.57M | -41.93%33.57M | -39.33%35.07M | --53.95M | --53.95M | --57.8M | --57.8M |
Other composite income | -60.98%-13.97M | -49.96%-14.3M | -949.87%-14.15M | -437.65%-7.23M | -18.42%-8.68M | -70.58%-9.53M | -123.83%-1.35M | 5.54%-1.34M | 1.10%-7.33M | 17.23%-5.59M |
Shareholders equity without minority interests | 34.20%2.12B | 33.85%2.12B | 32.59%2.01B | 5.53%1.59B | 6.01%1.58B | 5.68%1.58B | 2.70%1.52B | 2.20%1.5B | 0.92%1.49B | 0.71%1.5B |
Minority interests | -106.19%-0.42 | -434.44%-10.1 | -49.89%4.56 | 25.09%21.94 | 435.64%6.78 | 100.00%3.02 | 100.00%9.1 | -100.00%17.54 | -100.00%-2.02 | -101.69%-203.35K |
Total shareholder equity | 34.20%2.12B | 33.85%2.12B | 32.59%2.01B | 5.53%1.59B | 6.01%1.58B | 5.69%1.58B | 2.73%1.52B | 1.23%1.5B | -0.09%1.49B | -0.12%1.5B |
Total liabilityies and equity | 17.28%2.87B | 15.12%2.88B | 19.45%2.99B | 2.73%2.56B | 5.25%2.45B | 0.96%2.51B | -3.79%2.5B | -1.67%2.49B | -1.65%2.32B | 4.98%2.48B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.